SCHEDULE OF FAIR VALUE PRICING MODEL (Details)		Nov. 02, 2023 Integer	Sep. 30, 2023 Integer	Jun. 30, 2023 Integer	Mar. 31, 2023 Integer	Jan. 09, 2023 Integer
Measurement Input, Share Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability measurement input	[1]	3.62	4.75	12.75	8.50	36.00
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contractual term (years)	[2]	5 years	4 years 9 months 18 days	5 years	5 years 3 months 18 days	5 years 6 months
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability measurement input		4.6	4.5	4.1	3.5	3.6
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability measurement input		100	100	100	100	100
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability measurement input		0	0	0	0	0

[1] Based on the trading value of common stock of Vivos Therapeutics, Inc. as of January 9, 2023 and each presented period ending date.

[2] The valuation of warrants is based on the expected term.